Financials Royal Sense Limited
Equities
544143
INE0QQG01019
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
135 INR | +2.04% | +7.06% | 0.00% |
05-31 | Royal Sense Limited Announces Board and Committee Resignations | CI |
05-07 | Royal Sense Launches New In-Vitro Diagnostic Kit | MT |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 71.35 | 67.49 | 122.7 |
EBITDA 1 | 2.278 | 2.229 | 13.62 |
EBIT 1 | 2.116 | 2.164 | 13.57 |
Operating Margin | 2.97% | 3.21% | 11.06% |
Earnings before Tax (EBT) 1 | 2.143 | 2.184 | 13.18 |
Net income 1 | 2.143 | 2.184 | 13.18 |
Net margin | 3% | 3.24% | 10.74% |
EPS | - | - | 3.820 |
Free Cash Flow | - | -5.588 | -4.274 |
FCF margin | - | -8.28% | -3.48% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 14/03/24 | 14/03/24 | 14/03/24 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | - | 2.92 | - |
Net Cash position 1 | 1.06 | - | 10.9 |
Leverage (Debt/EBITDA) | - | 1.31 x | - |
Free Cash Flow | - | -5.59 | -4.27 |
ROE (net income / shareholders' equity) | - | 38.4% | 66.4% |
ROA (Net income/ Total Assets) | - | 9.58% | 18.9% |
Assets 1 | - | 22.81 | 69.71 |
Book Value Per Share | - | - | 9.600 |
Cash Flow per Share | - | - | 4.680 |
Capex 1 | 1.04 | - | - |
Capex / Sales | 1.46% | - | - |
Announcement Date | 14/03/24 | 14/03/24 | 14/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 7.94M | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- 544143 Stock
- Financials Royal Sense Limited